Upper Limb Spasticity Clinical Trial
Official title:
A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport®) in Comparison With OnabotulinumtoxinA (Botox®) When Treating Adults With Upper Limb Spasticity
This study is aiming to demonstrate the non-inferiority of AbobotulinumtoxinA (aboBoNT-A) versus OnabotulinumtoxinA (onaBoNT-A) as the primary safety endpoint, and the superiority of aboBoNT-A over onaBoNT-A with respect to duration of response as the key secondary efficacy endpoint when used at optimal doses according to approved prescribing information of each product.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02454803 -
Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice
|
||
Completed |
NCT00945295 -
Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity
|
N/A | |
Active, not recruiting |
NCT05956509 -
Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity
|
Phase 1/Phase 2 | |
Completed |
NCT00465738 -
IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity
|
Phase 3 | |
Completed |
NCT02321436 -
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
|
Phase 4 | |
Completed |
NCT00430196 -
BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity
|
Phase 4 | |
Completed |
NCT03821402 -
Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity
|
Phase 2 | |
Terminated |
NCT02888548 -
Randomised, Evaluation-blinded, Crossover, Controlled Study Assessing Dynamic Hand Splinting in Adults With Post-stroke Hemiplegia (Orthox)
|
N/A | |
Completed |
NCT01863901 -
Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device
|
N/A |